Skip to main content
Scholar Rock Holding Corp logo

Scholar Rock Holding Corp — Investor Relations & Filings

Ticker · SRRK ISIN · US80706P1030 LEI · 549300Z1FLPGL4OWJ459 US Professional, scientific and technical activities
Open in API
Filings indexed 605 across all filing types
Latest filing 2021-11-17 Capital/Financing Update
Country US United States of America
Listing US SRRK

About Scholar Rock Holding Corp

https://scholarrock.com/

Scholar Rock Holding Corp. is a late-stage biopharmaceutical company that discovers, develops, and delivers therapies for serious diseases, with a focus on neuromuscular disorders. The company's scientific approach is centered on selectively targeting protein growth factors in their latent, inactive state. This proprietary platform aims to modulate biological functions with high specificity, representing a novel method compared to traditional approaches that target already activated proteins. Founded on pioneering research from Harvard Medical School and Boston Children's Hospital, Scholar Rock is developing a new class of medicines to address the underlying causes of disease.

Recent filings

Filing Released Lang Actions
FORM 8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events or changes that shareholders should know about. The content describes an amendment to a loan and security agreement, which is a financing-related update. It is not a full financial report, earnings release, or management discussion. The document is relatively short (4151 characters) and focuses on a material definitive agreement amendment related to financing. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2021-11-17 English
OWNERSHIP DOCUMENT
Director's Dealing
2021-11-16 English
SCHOLAR ROCK HOLDING CORPORATION 8-K
Earnings Release Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated November 9, 2021, reporting the issuance of a press release announcing financial and operating results for the quarter ended September 30, 2021. The text states that the press release is furnished as an exhibit and that the Form 8-K is intended to furnish information rather than file a full report. The document does not contain the actual financial statements or detailed financial data but rather references the press release. This matches the characteristics of an Earnings Release (ER), which is the initial announcement of quarterly financial results. The document length is 3407 characters, which is relatively short and consistent with a Form 8-K earnings release announcement. Therefore, the correct classification is ER with high confidence.
2021-11-09 English
10-Q
Interim / Quarterly Report Q3 2021
2021-11-09 English
OWNERSHIP DOCUMENT
Director's Dealing
2021-10-05 English
OWNERSHIP DOCUMENT
Director's Dealing
2021-09-21 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.